MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).

NCT07593261 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Carcinomatosis
Oligometastatic Disease
Peritoneal Metastases

Interventions

DEVICE: MRI-guided stereotactic body radiotherapy

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS